Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6071855

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O[C@H]1CNC[C@@H]1N1CCN(c2ccccc2Cl)CC1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 3/20 0.45
DRD2 P14416 2/20 0.41
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
CYP2C19 P33261 2/20 0.41
SLC6A3 Q01959 2/20 0.41
ALDH1A1 P00352 2/20 0.40
ADRB1 P08588 1/20 0.40
NOTUM Q6P988 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
DPP4 P27487 1/20 0.40
HTR1A P08908 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6071717 0.87 TTR (0.46) SLC18A3DRD2DRD3HTR1AAKR1C3
Trifluoroacetic Acid SCHEMBL5814484 0.87 TTR (0.46) SLC18A3DRD2DRD3HTR1AAKR1C3
Trifluoroacetic Acid SCHEMBL6072071 0.85 SLC18A3 (0.62) SLC18A3MAPK1
Trifluoroacetic Acid SCHEMBL6072334 0.82 SLC18A3 (0.49) SLC18A3ALDH1A1ADRB1NOTUMDPP4
Trifluoroacetic Acid SCHEMBL6072038 0.82 SLC18A3 (0.49) SLC18A3CYP1A2CYP3A4CYP2D6CYP2C9
Trifluoroacetic Acid SCHEMBL6071612 0.81 SLC18A3 (0.54) SLC18A3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3106234 0.80 DRD2 (0.54) SLC18A3DRD2DRD4DRD3ADRB1
Trifluoroacetic Acid SCHEMBL6071622 0.80 ALDH1A1 (0.44) SLC18A3ALDH1A1HTR1ALMNAKDM4E
Trifluoroacetic Acid SCHEMBL6071803 0.80 KDM4E (0.45) SLC18A3CYP3A4CYP2C9ALDH1A1GAA
Trifluoroacetic Acid SCHEMBL6071817 0.79 FAAH (0.43) SLC18A3CYP2C19DPP4KCNH2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060189628-A1 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189628-A1 Compounds useful as chemokine receptor antagonists ACKR3, CCR5, CXCR2 SLC18A3 2263/4885DRD2 3087/4885DRD4 4020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.